CA
EW icon

Commerzbank Aktiengesellschaft’s Edwards Lifesciences EW Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Sell
3,377
-1,279
-27% -$107K 0.01% 300
2026
Q1 		$373K Sell
4,656
-193
-4% -$15.9K 0.01% 287
2025
Q4 		$413K Sell
4,849
-131
-3% -$10.8K 0.01% 298
2025
Q3 		$388K Hold
4,980
– – 0.01% 286
2025
Q2 		$390K Hold
4,980
– – 0.01% 268
2025
Q1 		$361K Hold
4,980
– – 0.01% 270
2024
Q4 		$370K Buy
4,980
+1,587
+47% +$111K 0.01% 252
2024
Q3 		$224K Buy
3,393
+978
+40% +$71.1K 0.01% 284
2024
Q2 		$224K Buy
2,415
+166
+7% +$14.7K 0.01% 230
2024
Q1 		$215K Sell
2,249
-604
-21% -$50.7K 0.01% 234
2023
Q4 		$218K Buy
+2,853
New +$199K 0.01% 194
2020
Q2 		– Sell
-14,388
Closed -$905K – 204
2020
Q1 		$905K Sell
14,388
-315,225
-96% -$22.7M 0.04% 193
2019
Q4 		$25.6M Buy
329,613
+80,337
+32% +$6.27M 0.25% 72
2019
Q3 		$18.3M Buy
249,276
+40,962
+20% +$2.88M 0.14% 128
2019
Q2 		$12.8M Buy
208,314
+29,706
+17% +$1.8M 0.1% 156
2019
Q1 		$11.4M Buy
178,608
+41,907
+31% +$2.39M 0.1% 158
2018
Q4 		$6.98M Buy
136,701
+37,986
+38% +$1.92M 0.07% 211
2018
Q3 		$5.73M Buy
98,715
+34,680
+54% +$1.7M 0.05% 260
2018
Q2 		$3.11M Sell
64,035
-13,629
-18% -$636K 0.03% 341
2018
Q1 		$3.61M Buy
77,664
+14,961
+24% +$650K 0.04% 311
2017
Q4 		$2.36M Sell
62,703
-1,440
-2% -$52.8K 0.03% 366
2017
Q3 		$2.34M Buy
64,143
+4,971
+8% +$190K 0.03% 342
2017
Q2 		$2.33M Buy
59,172
+5,100
+9% +$186K 0.04% 315
2017
Q1 		$1.7M Sell
54,072
-21,579
-29% -$676K 0.03% 372
2016
Q4 		$2.36M Buy
75,651
+60,972
+415% +$1.98M 0.03% 321
2016
Q3 		$590K Buy
14,679
+861
+6% +$32.4K 0.01% 529
2016
Q2 		$459 Sell
13,818
-5,958
-30% -$204K ﹤0.01% 698
2016
Q1 		$581K Sell
19,776
-19,338
-49% -$534K ﹤0.01% 641
2015
Q4 		$1.03M Buy
39,114
+20,490
+110% +$532K 0.01% 641
2015
Q3 		$441K Sell
18,624
-53,532
-74% -$1.29M ﹤0.01% 823
2015
Q2 		$1.71M Sell
72,156
-13,932
-16% -$314K 0.01% 652
2015
Q1 		$2.04M Sell
86,088
-15,804
-16% -$355K 0.01% 594
2014
Q4 		$2.16M Sell
101,892
-97,644
-49% -$1.96M 0.01% 647
2014
Q3 		$3.4M Buy
199,536
+43,908
+28% +$693K 0.01% 603
2014
Q2 		$2.23M Sell
155,628
-16,812
-10% -$228K 0.01% 686
2014
Q1 		$2.13M Sell
172,440
-45,618
-21% -$526K 0.01% 698
2013
Q4 		$2.37M Sell
218,058
-52,338
-19% -$590K 0.01% 703
2013
Q3 		$3.14M Sell
270,396
-39,150
-13% -$458K 0.02% 614
2013
Q2 		$3.47M Buy
+309,546
New +$3.66M 0.02% 641

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Commerzbank Aktiengesellschaft's EW Position: Q2 2026 in Review

Commerzbank Aktiengesellschaft reduced its Edwards Lifesciences (EW) stake by 27% in Q2 2026, selling an estimated $107K and leaving 3,377 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #300.

Commerzbank Aktiengesellschaft first reported a position in EW in Q2 2013 and has held it in 39 quarters since. The position peaked at $25.6M in Q4 2019. 837 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Commerzbank Aktiengesellschaft held 3,377 shares of Edwards Lifesciences worth $305K as of Q2 2026.
  • Commerzbank Aktiengesellschaft sold 1,279 Edwards Lifesciences shares in Q2 2026, an estimated $107K.
  • Edwards Lifesciences made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #300 holding.
  • Commerzbank Aktiengesellschaft first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 39 quarters since.
  • Commerzbank Aktiengesellschaft's Edwards Lifesciences position peaked at $25.6M in Q4 2019.
  • 837 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.